Sath Shukla Spero Therapeutics, Inc. (SPRO) insider trading activity

Sath Shukla is CEO & President of Spero Therapeutics, Inc.. Currently has a direct ownership of 1.14 Million shares of SPRO, which is worth approximately $1.52 Million. The most recent transaction as insider was on Aug 27, 2024, when has been sold 2,757 shares (Common Stock) at a price of $1.35 per share, resulting in proceeds of $3,721. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.14M

2.99% 3M change

99.27% 12M change

Total Value Held $1.52 Million

Sath Shukla Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 27 2024	SELL Open market or private sale	$3,721 $1.35 p/Share	2,757 Reduced 0.24%	1,140,809 Common Stock
Aug 05 2024	SELL Open market or private sale	$23,109 $1.31 p/Share	17,641 Reduced 1.52%	1,143,566 Common Stock
Aug 02 2024	SELL Open market or private sale	$19,536 $1.32 p/Share	14,800 Reduced 1.26%	1,161,207 Common Stock
Feb 05 2024	SELL Open market or private sale	$65,384 $1.45 p/Share	45,093 Reduced 3.69%	1,176,007 Common Stock
Feb 02 2024	SELL Open market or private sale	$42,334 $1.37 p/Share	30,901 Reduced 2.47%	1,221,100 Common Stock
Feb 01 2024	BUY Grant, award, or other acquisition	-	679,501 Added 35.18%	1,252,001 Common Stock
Aug 29 2023	SELL Open market or private sale	$5,411 $1.3 p/Share	4,163 Reduced 0.72%	572,500 Common Stock
Aug 28 2023	SELL Open market or private sale	$2,336 $1.26 p/Share	1,854 Reduced 0.32%	576,663 Common Stock
Aug 01 2023	BUY Grant, award, or other acquisition	-	266,000 Added 31.5%	578,517 Common Stock
Feb 02 2023	SELL Open market or private sale	$17,392 $1.83 p/Share	9,504 Reduced 2.95%	312,517 Common Stock
Feb 01 2023	BUY Grant, award, or other acquisition	-	265,957 Added 45.23%	322,021 Common Stock
Aug 29 2022	SELL Open market or private sale	$5,355 $0.89 p/Share	6,017 Reduced 9.69%	56,064 Common Stock
Feb 01 2022	BUY Grant, award, or other acquisition	-	38,014 Added 37.98%	62,081 Common Stock
Aug 26 2021	BUY Grant, award, or other acquisition	-	24,067 Added 50.0%	24,067 Common Stock

Sath Shukla

CEO & President

Cambridge, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SPRO shares.

Notify only if

Value

Insider Trading

Get notified when an Spero Therapeutics, Inc. insider buys or sells SPRO shares.

Notify only if

Operation

Value

Type

News

Receive news related to Spero Therapeutics, Inc.

Track Activities on SPRO

Account